How to Optimize Goal-Directed Medical Therapy (GDMT) in Patients with Heart Failure.
Publication/Presentation Date
9-1-2024
Abstract
PURPOSE OF REVIEW: Heart failure is a clinical syndrome with signs and symptoms from underlying cardiac abnormality and evidence of pulmonary or systemic congestion on laboratory testing or other objective findings (Bozkurt et al. in Eur J Heart Fail 23:352-380, 2021). Heart failure with reduced ejection fraction (HFrEF), when heart failure is due to underlying reduction in ejection fraction to
RECENT FINDINGS: Use of medications from each class as recommended in the 2022 Guidelines can provide significant morbidity and mortality benefits for our patients. Despite advances in therapeutics for patients with HFrEF, patients are frequently under treated and more research is needed to help optimize management of these complicated patients.
Volume
26
Issue
9
First Page
995
Last Page
1003
ISSN
1534-3170
Published In/Presented At
Newman, E., Kamanu, C., Gibson, G., & Brailovsky, Y. (2024). How to Optimize Goal-Directed Medical Therapy (GDMT) in Patients with Heart Failure. Current cardiology reports, 26(9), 995–1003. https://doi.org/10.1007/s11886-024-02101-x
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
39093374
Department(s)
Administration and Leadership
Document Type
Article